250 related articles for article (PubMed ID: 33177052)
21. Interim assessment of liver damage in patients with sickle cell disease using new non-invasive techniques.
Drasar E; Fitzpatrick E; Gardner K; Awogbade M; Dhawan A; Bomford A; Suddle A; Thein SL
Br J Haematol; 2017 Feb; 176(4):643-650. PubMed ID: 27984631
[TBL] [Abstract][Full Text] [Related]
22. Hepatic iron overload in children with sickle cell anemia on chronic transfusion therapy.
Brown K; Subramony C; May W; Megason G; Liu H; Bishop P; Walker T; Nowicki MJ
J Pediatr Hematol Oncol; 2009 May; 31(5):309-12. PubMed ID: 19415007
[TBL] [Abstract][Full Text] [Related]
23. Venous thromboembolism in adults with sickle cell disease: experience of a single centre in the UK.
van Hamel Parsons V; Gardner K; Patel R; Thein SL
Ann Hematol; 2016 Jan; 95(2):227-32. PubMed ID: 26490882
[TBL] [Abstract][Full Text] [Related]
24. Age of first pain crisis and associated complications in the CASiRe international sickle cell disease cohort.
Tartaglione I; Strunk C; Antwi-Boasiako C; Andemariam B; Colombatti R; Asare EV; Piccone CM; Manwani D; Boruchov D; Tavernier F; Farooq F; Akatue S; Oteng B; Urbonya R; Wilson S; Owda A; Bamfo R; Boatemaa GD; Rao S; Zempsky W; Sey F; Inusa BP; Perrotta S; Segbefia C; Campbell AD
Blood Cells Mol Dis; 2021 May; 88():102531. PubMed ID: 33401140
[TBL] [Abstract][Full Text] [Related]
25. Alternative donor: αß/CD19 T-cell-depleted haploidentical hematopoietic stem cell transplantation for sickle cell disease.
Foell J; Kleinschmidt K; Jakob M; Troeger A; Corbacioglu S
Hematol Oncol Stem Cell Ther; 2020 Jun; 13(2):98-105. PubMed ID: 32202248
[TBL] [Abstract][Full Text] [Related]
26. Paediatric haematologists' attitudes regarding haematopoietic cell transplantation as treatment for sickle cell disease.
Stallings AM; Majhail NS; Nowacki AS; Onimoe GI; Hanna R; Piccone CM
Br J Haematol; 2020 Mar; 188(6):976-984. PubMed ID: 31713857
[TBL] [Abstract][Full Text] [Related]
27. The Liver in Sickle Cell Disease.
Lacaille F; Allali S; de Montalembert M
J Pediatr Gastroenterol Nutr; 2021 Jan; 72(1):5-10. PubMed ID: 32740518
[TBL] [Abstract][Full Text] [Related]
28. Non-transferrin-bound labile plasma iron and iron overload in sickle-cell disease: a comparative study between sickle-cell disease and beta-thalassemic patients.
Koren A; Fink D; Admoni O; Tennenbaum-Rakover Y; Levin C
Eur J Haematol; 2010 Jan; 84(1):72-8. PubMed ID: 19732137
[TBL] [Abstract][Full Text] [Related]
29. Sickle cell hepatopathy.
Banerjee S; Owen C; Chopra S
Hepatology; 2001 May; 33(5):1021-8. PubMed ID: 11343226
[No Abstract] [Full Text] [Related]
30. Sickle cell hepatopathy.
Bandyopadhyay R; Bandyopadhyay SK; Dutta A
Indian J Pathol Microbiol; 2008; 51(2):284-5. PubMed ID: 18603711
[TBL] [Abstract][Full Text] [Related]
31. Demands and challenges for patients with sickle-cell disease requiring hematopoietic stem cell transplantation in Saudi Arabia.
Alsultan A; Jastaniah W; Al Afghani S; Al Bagshi MH; Nasserullah Z; Al-Suliman AM; Alabdulaali MK
Pediatr Transplant; 2016 Sep; 20(6):831-5. PubMed ID: 27477851
[TBL] [Abstract][Full Text] [Related]
32. Sickle cell hepatic crisis in Nigerian children.
Kaine WN; Udeozo IO
J Trop Pediatr; 1988 Apr; 34(2):59-64. PubMed ID: 3385853
[No Abstract] [Full Text] [Related]
33. Managing patients with sickle cell disease in primary care.
Hehre RJ
JAAPA; 2020 Oct; 33(10):21-28. PubMed ID: 32941305
[TBL] [Abstract][Full Text] [Related]
34. Red blood cell transfusion to treat or prevent complications in sickle cell disease: an overview of Cochrane reviews.
Fortin PM; Hopewell S; Estcourt LJ
Cochrane Database Syst Rev; 2018 Aug; 8(8):CD012082. PubMed ID: 30067867
[TBL] [Abstract][Full Text] [Related]
35. Sickle Cell Disease Complicated by Iron Overload: An Under-Recognized Risk Factor for Vibrio vulnificus Infection.
El Chaer F; Holtzman NG; Baer MR; Zimrin AB; Law JY
Acta Haematol; 2018; 139(3):199-200. PubMed ID: 29734168
[No Abstract] [Full Text] [Related]
36. Increased complications of chronic erythrocytapheresis compared with manual exchange transfusions in children and adolescents with sickle cell disease.
Woods D; Hayashi RJ; Binkley MM; Sparks GW; Hulbert ML
Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28544309
[TBL] [Abstract][Full Text] [Related]
37. Sickle cell hepatopathy.
Sheehy TW
South Med J; 1977 May; 70(5):533-8. PubMed ID: 870977
[TBL] [Abstract][Full Text] [Related]
38. Liver Transplantation After Hematopoietic Stem Cell Transplant for the Treatment of Sickle Cell Disease: A Case Report.
de Sousa Arantes Ferreira G; Ferreira CA; Watanabe ALC; Trevizoli NC; Murta MCB; Figueira AVF; de Fatima Couto C
Transplant Proc; 2022 Jun; 54(5):1394-1397. PubMed ID: 35659126
[TBL] [Abstract][Full Text] [Related]
39. Sickle cell diseases: What can nuclear medicine offer?
Niccoli Asabella A; Altini C; Nappi AG; Lavelli V; Ferrari C; Marzullo A; Loiodice A; Rubini G
Hell J Nucl Med; 2019; 22(1):2-3. PubMed ID: 30843001
[TBL] [Abstract][Full Text] [Related]
40. Transfusion Therapy in Children With Sickle Cell Disease.
Inati A; Mansour AG; Sabbouh T; Amhez G; Hachem A; Abbas HA
J Pediatr Hematol Oncol; 2017 Mar; 39(2):126-132. PubMed ID: 27509379
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
